Airway dimensions during pediatric anesthesia

Upper airway morphology and hemodynamic changes during sedation with dexmedetomidine and propofol for neuro-diagnostic procedures

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/03/006721

Enrollment

Registered

2016-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- neurological disease

Interventions

Intervention1: Sedation: propofol and dexmedetomidine will be compared for their effects on airway dimension during MRI study. STudy duration will last for a maximum of 90 minutes Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: children with neurological pathology undergoing MRI study with sedation or anesthesia

Exclusion criteria

Exclusion criteria: nonneurological pathology, adults

Design outcomes

Primary

Measure	Time frame
Upper airway dimension difference 10%Timepoint: post drug administration	—

Secondary

Measure	Time frame
Hemodynamic and respiratory changesTimepoint: post drug administration	—

Countries

India

Contacts

Public ContactSriganesh K

NIMHANS

drsri23@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026